MacroGenics, Inc.
MGNX
$4.62
-$0.24-4.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.78M | 41.23M | 72.84M | 22.24M | 13.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.78M | 41.23M | 72.84M | 22.24M | 13.19M |
| Cost of Revenue | 44.50M | 44.09M | 44.30M | 49.70M | 45.10M |
| Gross Profit | -23.73M | -2.86M | 28.54M | -27.46M | -31.91M |
| SG&A Expenses | 9.71M | 9.24M | 9.91M | 9.30M | 10.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.21M | 53.32M | 54.20M | 59.00M | 55.82M |
| Operating Income | -33.44M | -12.10M | 18.64M | -36.76M | -42.62M |
| Income Before Tax | -36.77M | -14.93M | 16.82M | -36.15M | -41.04M |
| Income Tax Expenses | -- | -777.00K | -- | 105.00K | -- |
| Earnings from Continuing Operations | -36.77M | -14.16M | 16.82M | -36.25M | -41.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.77M | -14.16M | 16.82M | -36.25M | -41.04M |
| EBIT | -33.44M | -12.10M | 18.64M | -36.76M | -42.62M |
| EBITDA | -31.75M | -10.39M | 20.43M | -34.85M | -40.85M |
| EPS Basic | -0.58 | -0.22 | 0.27 | -0.57 | -0.65 |
| Normalized Basic EPS | -0.36 | -0.15 | 0.17 | -0.36 | -0.41 |
| EPS Diluted | -0.58 | -0.22 | 0.27 | -0.57 | -0.65 |
| Normalized Diluted EPS | -0.36 | -0.15 | 0.17 | -0.36 | -0.41 |
| Average Basic Shares Outstanding | 63.45M | 63.28M | 63.23M | 63.14M | 62.97M |
| Average Diluted Shares Outstanding | 63.45M | 63.28M | 63.28M | 63.14M | 62.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |